Stock Updates

How has Monsanto Company:(NYSE:MON) performed recently?

Monsanto Company (NYSE: MON) is a large market cap stock with a market cap of 46347.89. It is in the Agricultural Chemicals industry and sector Basic Materials, with a current P/E of 44.28, a forward P/E of 21.11 and EPS of 2.38. At a stock price of 105.69 (0.42%) it has a dividend yield of 2.05%.

EPS growth for the last five years have been 19.10%, more recently this last year it has grown by -8.60%. The next year growth is going to be about 11.80% and more long-term 6.68% after five years. EPS growth quarter over quarter is -31.90%. Sales growth for the past five years have been 7.40% and sales growth quarter over quarter is -8.50%.

For performance, Monsanto Company the past week has seen a gain of -1.57%. For the last month performance for Monsanto Company is 0.99%. While the last quarter is 5.88% and half year, 22.35%. Finally for the year, performance is 4.28%.

The 52-week high for Monsanto Company, is at -7.00%, and for the 52-week low it comes to a value of 33.20%. The 20-day simple moving average is 0.34% and 10.57% for the 200-day simple moving average.

Volatility for the week is at 1.38%, and for the month it is 1.69%. Monsanto Company, has a target price of 112.71.

In terms of debt, long term debt/equity is 1.56, and for total debt/equity Monsanto Company has 2.06. The gross margin is 51.70%, while operating margin is 15.60%, the profit margin is 7.80%. The current ratio is 1.5 and the quick ratio is 0.9.

Insider ownership is at 0.20%, with instituitional ownership at 79.90%. Monsanto Company has a payout ratio of 86.10%. With the total shares outstanding coming to 440.36. The shares float is 436.26, with the float short at 1.01%, with short ratio coming to 0.96.

In terms of returns, the return on assets see Monsanto Company, get 5.00%, with its returns on investment at 16.60%. Return on equity is 20.80%. So will the investors see the target price of 112.71, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Peter Clarke

Leave a Comment